Legis Daily

Federal Clarity for Kratom Consumers Act

USA117th CongressS-5316| Senate 
| Updated: 12/20/2022
Mike Lee

Mike Lee

Republican Senator

Utah

Cosponsors (1)
Cory A. Booker (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2022

Latest Companion Bill Action

HR 117-9634
Introduced in House
Dec 20, 2022
Introduced in Senate
Dec 20, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • December 20, 2022

    Latest Companion Bill Action

    HR 117-9634
    Introduced in House


  • December 20, 2022
    Introduced in Senate


  • December 20, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Related Bills

  • HR 117-9634: Federal Clarity for Kratom Consumers Act
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding

Federal Clarity for Kratom Consumers Act

USA117th CongressS-5316| Senate 
| Updated: 12/20/2022
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2022

Latest Companion Bill Action

HR 117-9634
Introduced in House
Dec 20, 2022
Introduced in Senate
Dec 20, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • December 20, 2022

    Latest Companion Bill Action

    HR 117-9634
    Introduced in House


  • December 20, 2022
    Introduced in Senate


  • December 20, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mike Lee

Mike Lee

Republican Senator

Utah

Cosponsors (1)
Cory A. Booker (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 117-9634: Federal Clarity for Kratom Consumers Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding